End-to-end solutions for all phases of drug development 

From early-stage clinical development to market access and drug commercialisation, we provide a full range of integrated pharma services — covering all phases of drug development — for small to mid-sized biotech and pharma companies.  

Our integrated pharma services simplify complex drug development pathways, transforming them into streamlined, patient-focused solutions that help you accelerate timelines while retaining control and maximising value.  

Together, we can bring transformative therapies to patients faster. 

Our integrated pharma services 

Worried the complex regulatory landscape will block your drug development pathway? Would cross-functional expertise and integration help you turn strategy into an executable clinical development plan?  

TMC Consulting provides expert-led strategic and operational pharma consulting services — spanning regulatory support, clinical development, pharmacovigilance, medical services and quality management. Our experienced specialists partner flexibly with you, integrating key roles and pharma services into your team to help you reach critical drug development milestones compliantly, quickly and cost-effectively. 

Is patient recruitment for your early-phase clinical trial taking longer than expected and threatening your drug development timeline? Concerned about high turnover rates amongst your service provider's team? 

TMC Clinical specialises in early-stage clinical development solutions for rare diseases, complex oncology and advanced therapeutic modalities. We combine the responsiveness of a specialist pharma services company with the expertise of a clinical research organisation, enabling you to accelerate timelines, reduce risk and move confidently towards global regulatory approvals. 

Need support to write, prepare and submit your marketing authorisation application? Want a commercial partner who can align your pharma market access strategy with regulatory timing? 

TMC Commercial provides flexible, full-service drug commercialisation solutions in the EU and UK —giving you the confidence and opportunity to build your own commercial presence without needing to out-license to a partner. We also have the specialist expertise to act as your Marketing Authorisation Holder (MAH), either as a temporary bridge or long-term solution. 

Strategic support across your product lifecycle  

From early-stage planning through clinical execution and commercial launch, our integrated pharma services provide strategic support and the right drug development solution at the right time in your product lifecycle.  

If you're looking to access cross-functional expertise to accelerate your drug development timeline, conduct seamless early-phase clinical trials for advanced therapeutics or gain EU and UK market access quickly and confidently, contact TMC today.   

Our integrated pharma services and end-to-end support enable you to retain control, maximise value and bring transformative therapies to patients faster.